10:00 AM – 4:00 PM
Endocrine Surgical Section Review of Endocrine Surgical Advancements Course
This session is supported by a generous educational grant from Medtronic.

10:00 AM – 11:00 AM
Instructional Courses (Concurrent Sessions)

Instructional Course 01: How to Improve the Patient Experience
Moderator: Carol Lewis

This panel discussion will focus on what falls under the umbrella of patient experience, from institutional to department programming, highlighting the interconnectedness of the modern medical center. Speakers will describe the different aspects of patient experience with an emphasis on creating a culture of value-based commitment with patient experience at its core.

At the conclusion of this session, participants will be able to:

• Recognize the contemporary scope of patient experience, from access to and coordination of care through the continuum of treatment and inclusive of patient advisory committees and resources, that is reflected in evaluations of hospitals and individual providers.
• Understand the importance of patient experience in an era of rising consumerism in health care.
• Demonstrate how patient experience data can drive quality improvement projects and, on an individual level, improve provider and care team communication with patients.

10:00 AM	Patient Experience: What’s Involved and How to Improve It	Carol Lewis
10:25 AM	Patient Experience in an Era of Rising Consumerism in Healthcare	Brian Moore
10:50 AM	Q&A

Instructional Course 02: Social Media in Head and Neck Practice              
Moderator: Arvind Badhey

We will use an open forum format facilitated by panelists to stimulate audience discussion regarding effective and safe use of social media as an oncologic surgeon. We will also provide an update on social media use as it pertains to medicine & HIPAA. In addition we will provide examples and poll the audience regarding meaningful and appropriate use of a variety of platforms.

At the conclusion of this session, participants will be able to:

• Assess and compare the variety of social media platforms that exist.
• Determine which is most appropriate for use by the oncologic surgeon.
• Discuss and describe examples of meaningful and safe utilization of social media

10:00 AM	Choose Your Platform	Arvind Badhey
10:05 AM	Audience Discussion
10:15 AM	Update on Safe & Appropriate Use	Alice Tang
10:20 AM	Audience Discussion
10:25 AM	Examples of Posts	Elizabeth Cottrill
10:30 AM	Audience Discussion
10:40 AM	Role of Social Media Summary
10:45 AM	What Can the Society Do?

Instructional Course 03: Identifying Populations at Risk
Moderator: Thomas Ow

Risk stratification for patients with cancers of the head and neck region is generally underdeveloped – screening approaches are not well established, and accurate and clinically applicable means of identifying patients at highest risk of recurrence, metastasis, toxicity, and mortality are not available. This lecture will identify critical knowledge gaps, unmet needs, current concepts, and potential developments aimed at improving the diagnosis, surveillance and treatment for patients at highest risk of morbidity and mortality from cancers of the head and neck region.  

At the conclusion of this session, participants will be able to:

• Identify populations of patients at greatest risk of developing or experiencing significant morbidity and/or mortality from cancers of the head and neck.
• Illustrate key knowledge gaps and unmet needs among current approaches toward the diagnosis and care delivery for patients at greatest risk of poor outcome from head and neck cancers.
• Appraise current and potential genomic and molecular biomarkers available for risk stratification among patients with cancers of the head and neck.

We will discuss evidence-based surgical and non-surgical management of advanced laryngeal and hypopharyngeal cancer. Topics will include: indications for upfront laryngectomy vs primary chemoradiation, surveillance and survivorship after treatment, neck dissection and reconstruction for salvage laryngectomy.

At the conclusion of this session, participants will be able to:

• Compare surgical and non-surgical treatment options and discuss indications in light of frailty.
• Describe indications for neck dissection and flap reconstruction during salvage laryngectomy.
• Implement surveillance and survivorship post treatment protocols for advanced laryngeal and hypopharyngeal cancer patients.

10:00 AM	T3/4 Larynx Cancer: To Operate or Not?	Melonie Nance
10:15 AM	Surveillance/Survivorship After Treatment	Melonie Nance
10:30 AM	Neck Dissection During Salvage Laryngectomy: Is it Required?	Kiran Kakarala
10:45 AM	Reconstruction for Salvage Laryngectomy: Flap or No Flap?/Free Flap or Regional Flap?	Kiran Kakarala

Instructional Course 05: Update in the Management of Biosphosphonate and Radiation Induced Osteonecrosis                        
Moderator: Brett Miles

Current management of maxillofacial osteonecrosis will be discussed from a medical and surgical perspective. Illustrative case based learning will be utilized with active audience participation and discussion. Radiation and Medication Related Osteonecrosis will be discussed.

At the conclusion of this session, participants will be able to:

• Differentiate the pathophysiology of osteoradionecrosis versus medication-related osteonecrosis of the jaw (MRONJ).
• Examine the use of hyperbaric oxygen for tissue salvage in osteoradionecrosis and including the appropriate regimen, and expected outcomes.
• Employ medical management strategies in osteoradionecrosis and MRONJ, and become familiar with dosing and administration.

10:00 AM	Introduction	Brett Miles
10:05 AM	Case 1 – ORN	Rusha Patel
10:20 AM	Case 2 – ORN	Heather Edwards
10:35 AM	Case 3 – MRONJ	Brett Miles
10:50 AM	Q&A

Instructional Course 06: Update on Surgery for NMSC – Beyond WLE and Mohs
Moderator: Kevin Emerick

This session will describe the current techniques and possible future techniques for excising high risk and locally advanced skin cancers. We will utilize case discussions to highlight the key techniques and principles.

At the conclusion of this session, participants will be able to:

• Describe the principles of Complete Circumferential Peripheral and Deep Margin Assessment and the various types of techniques included in this type of assessment.
• Understand the strengths and weaknesses of various CCPDMA techniques.
• Understand some of the key biological behaviors and histopathologic features that can guide the use of improved surgical techniques.

10:00 AM	Introduction	Kevin Emerick
10:05 AM	Principles of CCPMDA	Jessica Yesenski
10:15 AM	Micrographic Mohs Surgery Basics	Vishal Patel
10:25 AM	New Techniques for the Future	Kevin Emerick
10:35 AM	Case Discussion

Instructional Course 07: Virtual Planning for Mandible and Maxillary Reconstruction                     
Moderator: Alexandra Kejner

This will be a case-based, defect centered instructional course addressing the following topics: Maxillary reconstruction, mandibular reconstruction, management of dental implants/orbital contents, and pedicle and soft tissue management during planning; troubleshooting situations, pearls/pitfalls. We will also discuss atypical reconstructions including Iliac crest, OCRFF, soft tissue plus custom plates, jaw in a day.

At the conclusion of this session, participants will be able to:

• Articulate the various reconstructive options based on defect type, patient characteristics, and functional needs.
• Implement tips and tricks for optimizing their engineer’s expertise during reconstruction.
• Plan and formulate various reconstruction plans and options with maximum efficiency.

10:00 AM	Virtual Surgical Planning for Maxillary Reconstruction	Chad Zender
10:15 AM	Virtual Surgical Planning for Mandibular Reconstruction	Byung Joo Lee
10:30 AM	Virtual Surgical Planning: Custom Plates, Dental Implants, Jaw in a Day	Alexandra Kejner
10:45 AM	Q&A

Instructional Course 08: Management Update: Nasopharyngeal Carcinoma
Moderator: Ivan El-Sayed

This instructional course will use literature review, anatomical description, and case studies to discuss up to date concepts in the management of nasopharyngeal carcinoma with systemic therapies and surgical management.

At the conclusion of this session, participants will be able to:

• Articulate the role, timing and common strategies for radiotherapy and chemotherapy and immunotherapy in the management of nasopharynx carcinoma.
• Discuss the indications, contraindications and risks of surgical management of nasopharynx cancer.
• Assess the prognostic significance of factors such as histopathology, viral etiology, and tumor staging.

10:00 AM	Introduction	Ivan El-Sayed
10:03 AM	Radiation and Systemic Therapy for Nasopharynx Cancer	Annie Chan
10:28 AM	Surgical Considerations for Nasopharynx Carcinoma	Ivan El-Sayed
10:51 AM	Q&A

Instructional Course 09: Practical Algorithm for Cutaneous Head and Neck Reconstruction
Moderator: Audrey H. Baker

This will be a case-based discussion on challenging questions regarding the reconstructive options in cutaneous defects of the head and neck. Cases will illustrate the difficult decision regarding margin assessment, timing of reconstruction with adjuvant therapy, and the decision tree to use free tissue transfer or local flap options.

At the conclusion of this session, participants will be able to:

• Incorporate current trends in margin assessment for cutaneous malignancy and integrate this into the reconstructive timeline.
• Allow for different flap reconstructive options based on site-specific and tissue-specific considerations.
• Consider options in timing for adjuvant therapy based on reconstructive and extirpative goals.

10:00 AM	Introduction	Audrey Baker
10:05 AM	Case 1: Margin Assessment and Reconstructive Timing	Audrey Baker
10:20 AM	Case 2: Adjuvant Treatment and Reconstructive Timing (Nasal Reconstruction)	Sydney Ch’ng
10:35 AM	Case 3: Local vs Pedicled vs Free Flap for Cutaneous Reconstruction	Alice Lin
10:50 AM	Putting It All Together

10:45 AM  – 12:00 PM
Instructional Courses (Concurrent Sessions)

Instructional Course 10: Total Maxillectomy – Resection and Reconstruction Pearls
Moderator: Michael Fritz

This session will provide a practical overview of maxillectomy, with detailed and clinically useful insights from experienced surgeons, whose topics will include a) how to choose the optimal approach; b) specific operative techniques and modifications; c) pitfalls; d) outcomes; and e) the challenges of preserving vs. exenterating the orbit. The first part of the course will focus on Resection and the second part will focus on Reconstruction; both parts will be robustly illustrated with diagrams and clinical photographs, with time for Discussion at the end.

At the conclusion of this session, participants will be able to:

• Choose optimal approaches to total maxillectomy with all its variations and technical modifications.
• Select appropriate reconstructive options for best functional and aesthetic outcomes after total maxillectomy, including revision reconstructions
• Recognize pitfalls and potential complications of total maxillectomy, and formulate plans to avoid and/or rectify them.

11:00 AM	Introduction	Michael Fritz
11:05 AM	Total Maxillectomy: Approaches, Techniques, Pitfalls, & Outcome	Daniel Nuss
11:25 AM	Reconstruction of Palatomaxillary Defects: Choices, Techniques, and Results	Michael Fritz
11:45 AM	Q&A

Instructional Course 11: Challenges and Considerations for Building a Practice for the Young Head and Neck Surgeon            
Moderator: Tammara L. Watts

We will hold an interactive session on topics important to early career head and neck surgeons including transitioning from training to practice, educational strategies when assuming the trainer role, clinical practice building and early career advancement. Common challenges and obstacles will be presented, and personal experiences will be shared by young AHNS members in diverse practice environments.

At the conclusion of this session, participants will be able to:

• Recognize common considerations in finding a first job including geography, academic vs. private practice, clinical opportunities, and research support, common compensation models, physician obligations, and the value of hiring an attorney to review your contract.
• Identify strategies to build your clinical team and consider the effects of regional differences on practice building.
• Describe approaches for early career advancement such as balancing clinical and academic efforts, finding time to develop research ideas, and applying for funding.

11:00 AM	Considerations When Finding Your First Job	Tammara Watts
11:12 AM	Practice Building	Caitlin McMullen
11:24 AM	Career Advancement Opportunities	Andres Bur
11:36 AM	Q&A

Instructional Course 12: How to Establish a Survivorship Program 
Moderator: Barbara Murphy

Head and Neck cancer patients may experience a number of unique and functionally significant late effects from cancer and its therapy.  Optimization of survivorship requires a systematic approach to identifying and managing these sequela. In this session we will review critical late effects experienced by head and neck cancer survivors and examine two different models of survivorship care. 

At the conclusion of this session, participants will be able to:

• Recognize the late effects issues that face head and neck cancer survivors and the impact on function and quality of life.
• Understand two distinct models of survivorship: the first in an academic setting and the second using a grass roots, patient focused approach and how to develop a private donor funded program.

11:00 AM	The Importance of a Systematic Approach to Head and Neck Cancer Survivorship	Barbara Murphy
11:10 AM	Models of Care: The University of Pittsburg Experience	Jonas Johnson
11:30 AM	Developing a Survivorship Program in a Low Resourced and Underfunded Setting	Danielle MacNeil
11:50 AM	Q&A

Instructional Course 13: Palliative Surgery in Pursuit of Health                   
Moderator: Alexander Langerman

Palliative surgery aims to improve the quality of a patient’s remaining life, but the stakes are high: in patients with limited life expectancy, complications can be devastating, and non curative palliative procedures still pose great risk. This case-based discussion will focus on decision making and key considerations for palliative surgical interventions in the head and neck.

At the conclusion of this session, participants will be able to:

• Define and contextualize palliative surgery.
• Understand opportunities for palliative surgery to enhance the care of head and neck patients.
• Develop an approach to decision-making regarding palliative interventions.

11:00 AM	Palliative Surgery	Alexander Langerman
11:30 AM	Palliative Surgery	Alessandra Colaianni

Instructional Course 14: Sialendoscopy – Pearls to Proficiency                   
Moderator: Rohan Walvekar

The instructional course is targeted at surgeons interested in learning more about Sialendoscopy and understanding what needs to be done to start a sialendoscopy practice successfully. 

At the conclusion of this session, participants will be able to:

• Create a pathway for initiating a sialendoscopy practice.
• Relate and recognize the breadth of sialendoscopy practice and impact they could have on the care of their patients with related conditions.
• Determine the feasibility of a sialendoscopy practice at their own institution and how to build a successful practice.

11:00 AM	Sialendoscopy – Getting Started	Rohan Walvekar
11:15 AM	Indications and Interventions	Boyd Gillespie
11:30 AM	Surgical and Practice Pitfalls	Rahmatulla Rahmati
11:45 AM	Sialendoscopy Outcomes and Patient Expectations	Jolie Chang

Instructional Course 15: Update on Non-surgical Treatment of Advanced Cutaneous Cancer      
Moderator: Renata Ferraroto

We will review current knowledge and future directions in the non-surgical treatment of advanced non-melanoma cutaneous cancer, including cutaneous squamous cell carcinoma, basal cell carcinoma and merkel cell carcinoma.

At the conclusion of this session, participants will be able to:

• Demonstrate an understanding of standard of care non-surgical treatment for non-melanoma skin cancers, with a focus on immunotherapy.
• Understand biomarkers being developed for disease monitoring and prediction of treatment benefit.
• Describe therapeutic advances and future directions in the management of non-melanoma skin cancers.

11:00 AM	Systemic Therapy for Advanced, Non-Resectable Non-Melanoma Skin Cancers: Standard of Care Available Options	Renatta Ferrarotto
11:25 AM	Novel Intratumoral and Systemic Therapies and Biomarkers of Disease Monitoring in Non-Melanoma Skin Cancer	Cecilia Schmalbach
11:50 AM	Q&A

Instructional Course 16: The Scapula Flap               
Moderator: Kevin Fung

This session will feature case-based presentations and practical tips and pearls for approaches to mid face, oromandibular, and other HN defects utilizing the subscapular system of flaps.

At the conclusion of this session, participants will be able to:

• Understand the surgical anatomy and technical aspects of the subscapular system of flaps.
• Understand common pitfalls and develop an approach to avoid them.
• Develop a practical approach to reconstruction of the midface and mandible.

11:00 AM	Introduction	Kevin Fung
11:05 AM	Oromandibular Defect Reconstruction	Judith Skoner
11:20 AM	Midface Defect Reconstruction	Antoine Eskander
11:35 AM	Pearls/Tips/Lessons Learned from Screwing Up	Kevin Fung
11:50 AM	Q&A

Instructional Course 17: Carotid Management in Skull Base Surgery         
Moderator: Ricardo Carrau

Considering all risk factors and alternatives for treatment is critical to prevent devastating complications. The course will provide guidelines toward the planning and execution of a protocol to stabilize intraoperative hemorrhage, including resuscitation, heparinization and focal packing (preferably with crushed muscle), followed by angiography and endovascular treatment. Clinical and radiological monitoring to prevent early and late complications will be discussed.

At the conclusion of this session, participants will be able to:

• Evaluate various options for the treatment of skull base tumors involving the ICA.
• Identify risk factors for an ICA injury.
• Plan the perioperative management of an injured ICA.

11:00 AM	Introduction	Ricardo Carrau
11:05 AM	Management of Skull Base Tumors Involving the ICA	C. Arturo Solares
11:25 AM	Perioperative Management of the Injured ICA	Nyall London
11:45 AM	Q&A

Instructional Course 18: Update in Facial Nerve Reconstruction                 
Moderator: Philip Daniel Knott

We will use a lecture/case based format for the 3 speakers to introduce the major salient topics for oncologic reanimation; namely treatment of the radical parotidectomy and/or lateral skull base surgery, treatment of post-treatment synkinesis, and salvage of the failed reanimation. The second half of the session will feature a case-based discussion format to review management strategies and treatment decision-making.

At the conclusion of this session, participants will be able to:

• Identify treatment algorithms that will yield the best post-treatment facial nerve reanimation outcomes.
• Manage both immediate and long term complications associated with facial nerve treatment challenges.
• Understand the rationale underlying selective denervation and selective myectomy with the optimization of outcomes encompassing both muscle tone and excursion.

11:00 AM	Immediate Management of Facial Nerve Sacrifice	Irene Kim
11:13 AM	Long-term Management of Facial Nerve Dysfunction	Leslie Kim
11:26 AM	Salvage of the Failed Reanimation	Daniel Knott
11:39 AM	Case Presentation and Q&A

12:00 PM – 1:30 PM
Lunch (on own)

1:30 PM – 2:30 PM
Instructional Courses (Concurrent Sessions)

Instructional Course 19: Head and Neck Lymphedema and Fibrosis          
Moderator: Heather Starmer

We will identify current therapy options and investigate related research for HNL and fibrosis.

At the conclusion of this session, participants will be able to:

• Distinguish between head and neck lymphedema and fibrosis.
• Demonstrate understanding of the relationship of lymphedema and fibrosis to functional outcomes.
• Identify appropriate treatment recommendations for patients with lymphedema and fibrosis.

1:30 PM	Introduction to Lymphedema and Fibrosis	Heather Starmer
1:37 PM	Differentiating Lymphedema and Fibrosis in Head and Neck Cancer Patients	Barbara Murphy
1:52 PM	The Functional Impact of Lymphoedema and Fibrosis on Swallowing, Speech and Voice	Claire Jeans
2:07 PM	Treatment of Head and Neck Lymphedema and Fibrosis	Holly McMillan
2:22 PM	Q&A

Instructional Course 20: Radiation Oncology Update: Opportunities for De-escalation                  
Moderator: Beth Beadle

We will review current data on the use of radiation therapy for head/neck cancers in the definitive and post-operative setting, with a focus on the clinical outcomes and toxicity from trials evaluating de-escalation. We will explore appropriate diseases in which to consider de-escalation and focus on methods of de-escalation, including use of surgery, altered chemotherapy regimens, and altered radiation regimens (dose, target, and technique).

At the conclusion of this session, participants will be able to:

• Identify appropriate head/neck cancers to consider de-escalation and potential risks/benefits.
• Evaluate the clinical trials testing de-escalation and interpret the results.
• Compare outcomes and toxicity from standard and de-escalated treatment paradigms.

1:30 PM	Standard of Care for Head/Neck Cancers: Benefits and Risks of “Full-dose” Treatment	Beth Beadle
1:50 PM	De-escalation for Head/Neck cancers: Benefits and Risks of “De-escalated” Treatments	Richard Wong
2:10 PM	Q&A

Instructional Course 21: What is the Current Role in Neoadjuvant Therapy           
Moderator: Eleni Rettig

We will present updates in the use of neoadjuvant immunotherapy and chemotherapy for both mucosal and cutaneous squamous cell carcinomas of the head and neck. Relevant clinical trials and sample cases will be discussed.

At the conclusion of this session, participants will be able to:

• Discuss recent clinical trials examining neoadjuvant immunotherapy for head and neck cutaneous and mucosal disease.
• Integrate findings from major clinical trials of neoadjuvant chemotherapy into management of head and neck mucosal disease.
• Recognize implications of neoadjuvant therapy for surgical planning.

1:30 PM	Introduction	Eleni Rettig
1:35 PM	Neoadjuvant Chemotherapy for Head and Neck Mucosal Disease and Larynx Preservation	Robert Haddad
1:55 PM	Neoadjuvant Immunotherapy for Mucosal and Cutaneous Head and Neck Disease	Ari Rosenberg
2:15 PM	Case Discussion and Q&A

Instructional Course 22: Intraoperative Nerve Monitoring – State of the Art
Moderator: Gregory Randolph

This instructional course will review basics pearls of application and applications of nerve monitoring for continuous monitoring and Superior laryngeal nerve monitoring.  We will conclude with a case-based panel.

At the conclusion of this session, participants will be able to:

• Troubleshoot neural monitoring systems.
• Apply neural monitoring to the superior laryngeal nerve.
• Discern the potential advantage of continuous monitoring.

1:30 PM	Introduction	Gregory Randolph
1:32 PM	IONM – Guidelines, Troubleshooting and Pearls	Amanda Silver
1:47 PM	IONM – What Outcomes Do We Affect ? Continuous vs Intermittent	Catherine Sinclair
2:02 PM	SLN
2:07 PM	IONM Panel Cases and Q&A

Instructional Course 23: The ‘How To’ of Sentinel Lymph Node Mapping for Oral Cavity Cancers
Moderator: Francisco Civantos

We will use a combination of case presentations and lectures to discuss patient selection, injection technique, surgical technique, pathological technique, and subsequent adjuvant management, of patients undergoing sentinel node biopsy for oral cavity cancer. Potential future innovations in techniques and management, including implications of the ongoing randomized trial comparing selective neck dissection and sentinel node biopsy, will be discussed.

At the conclusion of this session, participants will be able to:

• Properly select patients with early oral cancer for sentinel node biopsy versus neck dissection or observation.
• Begin developing their surgical technique for sentinel node biopsy, in the context of gamma probe guided neck dissections, (or refine their surgical technique for sentinel node biopsy, if already experienced).
• Discuss and understand the newest technical innovations in pathology and surgical technique for the selection of patients for sentinel node, for removal of sentinel nodes, and for identification of small metastases. Implications of these innovations, and potential innovations of an ongoing randomized trial will be understood.

1:30 PM	Patient Selection for Sentinel Node Biopsy: Current Approach and Possible Future Innovations	Karen Choi
1:45 PM	Surgical Technique of Sentinel Node Biopsy for Oral cancer: Standards and Controversies	Sandeep Samant
2:00 PM	New Innovations and Developments in Minimally Invasive Neck Management	Francisco Civantos
2:15 PM	Q&A

Instructional Course 24: Advances in the Management of Head and Neck Melanoma                  
Moderator: Alex Mlynarek

This session will discuss recent advances in the non-surgical management of high-risk and metastatic melanoma. This will include a discussion of new targeted therapy, immunotherapy, and oncolytic virus strategies as well as the current approach to treatment planning for patients with high-risk melanoma. Additional description of advances in the adjuvant and neoadjuvant setting will be discussed, including the role for imaging and predictive biomarker analysis in patient monitoring and treatment decision making.

At the conclusion of this session, participants will be able to:

• Distinguish the different mechanisms and indications for recently approved medical therapy for patients with head and neck melanoma.
• Develop a rational diagnostic and treatment strategy for patients with high-risk and metastatic head and neck melanoma.
• Describe the role of neoadjuvant and adjuvant treatment for patients presenting with locally advanced head and neck melanomas.

1:30 PM	Role, Indications and Technique of SLNB in 2023	Alex Mlynarek
1:50 PM	Adjuvant and Neoadjuvant Systemic Treatments	Kerwin Shannon
2:10 PM	Current Trials, Additions to Immunotherapy/Targeted Therapies for Advanced/Metastatic Disease	Howard Kaufman

Instructional Course 25: Local and Regional Flaps in Oral Cavity Reconstruction              
Moderator: Stephen Bayles

This session will explore local and regional flap options for oral cavity defects when microvascular options are unavailable or potentially inappropriate. It will outline selection criteria, advantages and disadvantages of an array of local and regional flap options to achieve acceptable reconstructive goals in appropriately chosen patients.

At the conclusion of this session, participants will be able to:

• Identify those patients best suited for local /regional reconstruction options for oral cavity defects over advanced techniques.
• Prioritize outcomes of reconstruction based on preoperative assessment of comorbidities, premorbid functional status, and donor site availability.
• Integrate, design, and execute on a wide variety of locoregional flap techniques to achieve successful reconstructive goals in some of the most challenged patients.

1:30 PM	Local and Regional Flaps in Oral Cavity Reconstruction	Stephen Bayles
2:00 PM	Local and Regional Flaps in Oral Cavity Reconstruction	Angela Haskin

Instructional Course 26: State of the Art in Paraganglioma Management               
Moderator: Matthew Old

We will use a case-based hybrid video format to discuss the etiology, diagnosis and management of head and neck paragangliomas and similar tumors and address the controversies and new treatment paradigms.

At the conclusion of this session, participants will be able to:

• Recognize the different etiologies and presentations of head and neck paragangliomas.
• Diagnose and recognize the spectrum of paragangliomas and similar tumors throughout the head and neck.
• Formulate treatment plans for head and neck paragangliomas.

1:30 PM	State of the Art Management of Head and Neck Paragangliomas	Matthew Old
2:00 PM	State of the Art Management of Head and Neck Paragangliomas	James Netterville

Instructional Course 27: Immunotherapy 101 – How it Works
Moderator: Nicole Schmitt

We will introduce the basic concepts of tumor immunology and strategies for immunotherapy. Next, we will review approved indications for immunotherapy in head and neck cancer and briefly highlight some ongoing research.

At the conclusion of this session, participants will be able to:

• Understand the basics of tumor immunology and immunotherapy.
• Articulate the approved indications for immunotherapy in head and neck cancer.
• Describe the rationale and endpoints of some ongoing clinical trials for immunotherapy in head and neck cancer.

1:30 PM	Basic Tumor Immunology	Nicole Schmitt
1:45 PM	Approved Indications and Ongoing Trials- Recurrent/Metastatic Disease	Michael Gibson
2:00 PM	Clinical Trials for Previously Untreated Disease

2:30 PM – 3:30 PM
Instructional Courses (Concurrent Sessions)

Instructional Course 28: SLP and Laryngology Care to Optimize Function after Transoral Robotic Oropharyngeal Surgery
Moderator: Katherine Hutcheson

Interdisciplinary protocols and procedures to improve function after TORS for oropharyngeal cancer will be discussed. The panel will review published protocols, supportive care models integrated into recent trials, and use a case based approach to highlight opportunities to personalize care and improve functional outcomes.  

At the conclusion of this session, participants will be able to:

• Describe published perioperative models of SLP care for swallowing support during hospitalization.
• Describe rationale for use of instrumental swallowing evaluation after TORS.
• Describe laryngological procedures to improve function after TORS including indications and expected outcomes.

2:30 PM	Surgical Selection and Technique Underlying Swallow Preservation After TORS	Michael Moore
2:42 PM	TORS SLP Care Pathway: Early Intervention Following TORS	Lauren Ottenstein
2:54 PM	Supportive Care and SLP Care After TORS in ORATOR/ORATOR2: What We Did and What We Learned	Julie Theurer
3:06 PM	Dysphagia After Oropharyngeal Cancer: What is the Surgeon’s Role?	Karuna Dewan
3:18 PM	Q&A

Instructional Course 29: Strategies for Successful Parathyroid Surgery                 
Moderator: Russell Smith

We will use multiple small presentations on specific aspects of preoperative assessment and intraoperative decision making to delineate strategies to ensure optimal outcomes with parathyroid surgery. We will conclude with a short discussion of a representative case to emphasize the concepts presented in the instructional course.

At the conclusion of this session, participants will be able to:

• Appropriately select patients who will likely benefit from parathyroid surgery.
• Formulate a plan for preoperative imaging for parathyroid pathology localization.
• Formulate an operative plan based upon patient assessment including preoperative imaging.

2:30 PM	Introduction and Preoperative Assessment	Erin Buczek
2:50 PM	Intraoperative Decision Making	Russell Smith
3:10 PM	Q&A

Instructional Course 30: Accelerate Your Clinical Research Program                     
Moderator: Joseph Curry

We will discuss key aspects of developing a translational and Basic science cancer program that fuels a strong clinical research program, as well as developing a clinical cancer research program around scientific program strengths. 

At the conclusion of this session, participants will be able to:

• Prioritize the key steps necessary for development of a successful cancer research program.
• Organize a successful plan to develop a cancer research program.
• Recognize the common pitfalls that sideline, stall and disrupt a cancer research program.

2:30 PM	Developing a Translational and Basic Science Cancer Program that Fuels a Strong Clinical Research Program	Sana Karam
3:00 PM	Developing a Clinical Cancer Research Program Around Scientific Program Strengths	Joseph Curry

Instructional Course 31: Update on Quality Metrics and Initiatives in Head and Neck Cancer
Moderator: Evan Graboyes

This session will describe the current landscape of quality metrics and quality improvement initiatives in head and neck oncology, with a focus on the recently approved Commission on Cancer quality metric for timely initiation of adjuvant radiation therapy following surgery for head and neck cancer. In addition, this session will identify strategies and challenges to establishing data collection infrastructure at the institutional and national levels, and highlight ongoing quality initiatives to decrease disparities in head and neck cancer access and outcomes.

At the conclusion of this session, participants will be able to:

• Recognize a variety of pre-treatment, treatment, and post-treatment quality metrics in head and neck oncology and choose metrics for reporting at their institution.
• Evaluate the rationale for the Commission on Cancer selecting the initiation of postoperative radiation therapy within 6 weeks of surgery as a quality metric in head and neck oncology and describe potential limitations of this quality metric.
• Convey how ongoing quality improvement initiatives can decrease disparities in access and outcomes among patients with head and neck cancer.

2:30 PM	Update on Quality Metrics and Initiatives in Head and Neck Cancer: Part 1	Evan Graboyes
3:00 PM	Update on Quality Metrics and Initiatives in Head and Neck Cancer: Part 2	Mark Prince

Instructional Course 32: Management of Laryngeal Dysplasia and Early Stage Cancer
Moderator: Dinesh Chhetri

We will use case presentations to discuss evaluation and management of laryngeal dysplasia and early stage laryngeal cancer. Principles of laser surgery, surgical techniques, and patient follow-up considerations will be highlighted.

At the conclusion of this session, participants will be able to:

• Differentiate the challenges in managing laryngeal dysplasia versus early laryngeal cancer.
• Develop an endoscopic treatment plan for laryngeal dysplasia and cancer.
• Generate a surveillance plan for laryngeal dysplasia and cancer.

2:30 PM	Laryngeal Dysplasia and Early Carcinoma: Assessment	Dinesh Chhetri
2:45 PM	Laryngeal Dysplasia and Early Carcinoma: Treatment	Joshua Schindler
3:00 PM	Laryngeal Dysplasia and Early Carcinoma: Outcomes and Surveillance	Dinesh Chhetri & Joshua Schindler
3:15 PM	Q&A

Instructional Course 33: Surgical Salvage for High-Risk Cutaneous Cancer Patients                    
Moderator: Steven Wang

We will provide a current update on surgical salvage treatment for high-risk cutaneous cancers, including conventional treatment failures, solid organ transplant recipients, and locally advanced recurrences with perineural/skull base involvement. The role of immunotherapy and other systemic therapies as part of salvage treatment strategies in this challenging patient population will also be discussed.

At the conclusion of this session, participants will be able to:

• Articulate the role of immunotherapy for those cutaneous cancer patients who fail conventional treatment.
• Manage solid organ transplant patients needing surgical salvage.
• Discuss role of surgery for cutaneous cancers with skull base and/or perineural recurrence.

2:30 PM	Surgical Salvage for Cutaneous Cancers in the Era of Immunotherapy	Steven Wang
2:55 PM	Surgical Salvage for Locally Advanced Cutaneous Cancers in Solid Organ Transplant Recipients	Marcus Monroe
3:20 PM	Q&A

Instructional Course 34: Genetics of Head and Neck Cancer – What You Need to Know              
Moderator: Luc Morris

Using case vignettes, we will discuss how to think about tumor genomic profiling for your patients with head and neck cancer, thyroid nodules, and how these tests can help with the management of advanced skin cancers, thyroid nodules, and oral cancers in young patients.

At the conclusion of this session, participants will be able to:

• Use tumor genomic profiling assays to take better care of patients.
• Recognize clinically actionable findings in tumor genomic data.
• Understand current research on leveraging tumor genomic biomarkers to develop better therapies.

2:30 PM	Introduction to Clinical Genomics in HNC	Luc Morris
2:38 PM	Young Patients with Oral Tongue Cancer: Genetic Insights	Theresa Guo
2:48 PM	Genomic Biomarkers to Guide Immunotherapy	Luc Morris
2:54 PM	Genetics of Advanced Skin SCC	Theresa Guo
3:04 PM	How to Interpret Thyroid Molecular and Genetic Assays	Luc Morris
3:12 PM	Q&A

Instructional Course 35: State of the Art in Management of Advanced Skull Base Malignancies   
Moderator: Shirley Su

This session will use short presentations and case examples to illustrate diagnostic and imaging “pearls” along with multi-modality management strategies for advanced skull base malignancies involving the orbit, facial skeleton and anterior cranial fossa. The role for endoscopic and open surgical approaches as well as neoadjuvant and adjuvant therapies will be presented.

At the conclusion of this session, participants will be able to:

• Recognize the role, timing and combinations of surgery, radiotherapy, chemotherapy and immunotherapy in the management of advanced anterior skull base malignancies.
• Identify the indications and contraindications for: i) endoscopic vs. open surgery and ii) orbital preservation vs. exenteration.
• Predict overall and disease specific survival based on a number of factors including histopathology, disease extent, margin status and adjuvant therapies.

2:30 PM	Introduction	Shirley Su
2:35 PM	Management Principles	Ian Witterick
2:45 PM	Surgical Approaches	Ivan El-Sayed
2:55 PM	Adjuvant/Neoadjuvant Therapies	Shirley Su
3:05 PM	Illustrative Case Examples

Instructional Course 36: Immunotherapy 201 – What to Expect       
Moderator: Michael Gibson

This session will focus on the following topics: Review of current IO status in HNSCC, the HNSCC immune landscape as we know it, ongoing trials that could shape the near-term, unmet needs, biomarker development, and promising agents and modalities.

At the conclusion of this session, participants will be able to:

• Identify major determinants of the tumor microenvironment in HNSCC.
• Appraise the next generation of immunotherapy agents in HNSCC.
• Compare utility of predictive biomarkers for immunotherapy in HNSCC.

2:30 PM	Current Status and Near Term Challenges in HNSCC Immunotherapy	Michael Gibson
2:52 PM	Promising Agents and Modalities in HNSCC Immunotherapy	Ezra Cohen
3:14 PM	Q&A

3:30 PM – 4:00 PM
PM Break

4:00 PM – 5:00 PM
Instructional Courses (Concurrent Sessions)

Instructional Course 37: Optimizing Post-Laryngectomy Function  
Moderator: Julia Maclean

Patients deserve optimal care to avoid complications and give them the highest chance to optimize quality of life after this life-changing surgery. In this session, participants will be educated on counseling, surgical techniques and rehabilitation strategies to optimize post-laryngectomy function.

At the conclusion of this session, participants will be able to:

• Recognize how several surgical techniques can influence post-surgery function.
• Use practical methods to manage the common problems seen with voicing and swallowing after laryngectomy.
• Understand the importance of a dedicated rehabilitation team after laryngectomy.

4:00 PM	Optimizing Rehabilitation and Avoiding Complications in Total Laryngectomy Surgery	Ryan Goepfert
4:10 PM	Surgical Considerations to Optimize Breathing, Voice and Swallowing	Michiel Vandenbrekel
4:20 PM	Dysphagia Following Total Laryngectomy	Tamar Kotz
4:30 PM	Case Discussion

Instructional Course 38: Nuances of Pediatric Thyroid Cancer                    
Moderator: Ken Kazahaya

We will present some of the differences and considerations in the management of pediatric thyroid cancer. We will present some preoperative, intraoperative, and post-operative management options particular to the pediatric population.

At the conclusion of this session, participants will be able to:

• Develop a better understanding of decisions regarding ultrasound-guided fine-needle aspiration in the pediatric population.
• Identify differences in intraoperative management between pediatric and adult patients.
• Understand some of the pediatric post-thyroidectomy treatment paradigms.

4:00 PM	Preoperative Considerations in Management of Pediatric Thyroid Cancer	Ryan Belcher
4:15 PM	Intraoperative Considerations in Management of Pediatric Thyroid Cancer	Gillian Diercks
4:30 PM	Post-Thyroidectomy Considerations in Pediatric Thyroid Cancer Management	Ken Kazahaya
4:45 PM	Q&A

Instructional Course 39: Accelerate Your Clinical Research II: Running Clinical Trials      
Moderator: Stephen Lai

Evaluation of medical interventions and surgical procedures that will alter the standard of care require the highest level of clinical evidence. We will discuss our experience in developing and activating clinical trials at the institutional and multi-institutional, cooperative group levels.

At the conclusion of this session, participants will be able to:

• Articulate the challenges and potential strategies related to patient accrual for clinical trials.
• Describe the challenges and potential solutions for funding and institutional support of clinical trials.
• Articulate the steps required to move a clinical trial from initial concept to formal activation.

4:00 PM	Challenges and Pitfalls in Clinical Trials	Derrick Lin
4:25 PM	Developing Cooperative Group Trials: Concept to Activation	Stephen Lai
4:50 PM	Q&A

Instructional Course 40: Tracheal Resection and Reconstruction   
Moderator: Eric Genden

In this session, we will discuss the approach to management of patients with tracheal stenosis. We will discuss standard and advanced techniques in diagnosis, management, and complications.

At the conclusion of this session, participants will be able to:

• Articulate the diagnostic and therapeutic approach to a patient with tracheal stenosis.
• Create a treatment algorithm for management of complex airway disease.
• Discuss and review management of complication of airway reconstruction.

4:00 PM	The Standard Approach and Management of Tracheal Stenosis	Alexander Gelbard
4:30 PM	The Management of Complex Tracheal Airway Stenosis	Eric Genden

Instructional Course 41: Patient Selection for Salvage Surgery                  
Moderator: Gina Jefferson

We will use evidence to provide patient considerations for salvage head and neck surgery including patients at risk for recurrent disease, medical and surgical factors that require consideration for salvage surgery and surgical interventions. We will approach the topic by subsite and address potential complications as well as prognosis.

At the conclusion of this session, participants will be able to:

• Describe HNC patients at risk for persistent/recurrent disease that surgeons would consider for surgical salvage intervention.
• Articulate by head and neck subsite potential surgical management strategies for persistent/recurrent disease.
• Discuss prognosis and anticipated functional outcomes for patients undergoing salvage surgery of the head and neck by subsite.

4:00 PM	Introduction: Who, Risk Factors	Gina Jefferson
4:10 PM	Salvage Surgery Considerations by Subsite	Benjamin Judson
4:25 PM	Microvascular Reconstruction Considerations	Gina Jefferson
4:40 PM	Prognosis, Complications and Functional Outcomes	Benjamin Judson
4:50 PM	Case Presentation
4:55 PM	Q&A

Instructional Course 42: NCI/NIDCR Sponsored Course – Early Detection
Moderator: Chad Brenner

In this session we will have an open discussion to explore the opportunities to incorporate Circulating tumor DNA (ctDNA) testing into the management of HPV+ HNSCC, in order to discuss the current limitations of testing that providers should know. Providers need to understand the potential benefits and limitations of ctDNA testing, such as the need for confirmation with imaging or tissue-based testing, the potential for false-positive or false-negative results, and the impact of the tumor burden on ctDNA levels.

At the conclusion of this session, participants will be able to:

• Distinguish between CLIA certified ctDNA tests available for patients as lab developed tests.
• Convey the limitations of current ctDNA testing strategies.
• Assess the value of ctDNA testing in different clinical scenarios.

4:00 PM	Circulating Tumor DNA Testing in HPV Related Oropharynx Cancer	Chad Brenner
4:15 PM	Q&A
4:20 PM	Implementation Challenges with CtDNA Testing for Early Detection	Catherine Haring
4:35 PM	Q&A
4:40 PM	EGFR-based PET Imaging for Early Detection of Cancer	Eben Rosenthal
4:55 PM	Q&A
5:00 PM	NIDCR-NCI’s Collaborations on Head and Neck Cancer Research	Chen Zhong & Wendy Wang
5:15 PM	Q&A
5:20 PM	Promoting Head and Neck Cancer Research in Early Detection, Prevention, and Biomarker Identification?

Instructional Course 43: Unusual But Very Useful Research Techniques – The Head and Neck Cancer Inter Group (HNCIG) Experience                    
Moderator: Hisham Mehanna

This session will discuss and explore research techniques that may not be widely used but can be very potent and useful when undertaking research, especially in large or international research collaborations. We will discuss the Delphi process for gaining consensus, the harmonization of trial outcome measures and using AI to collect large amounts of data. We will then have a discussion panel on challenges of building international collaborations and running multinational studies and how to address them. This session promises to be interesting, informative and instructional, and is of use to all researchers from students all the way to professors.

At the conclusion of this session, participants will be able to:

• Articulate what each of these novel research methodologies means and circumstances where they would be useful.
• Illustrate examples of when to use each method.
• Choose the method most appropriate for the research question when undertaking research in the future.

4:00 PM	The Process of Gaining Consensus for Low-evidence Conditions	Christina Henson
4:10 PM	Harmonization of HNC Trial Outcome Measures Across the World	Sue Yom
4:20 PM	AI-driven Data Collection – The TACTIC Multinational Study	Sujith Baliga
4:30 PM	Discussion Panel: The Challenges of Building International Collaborations and Running Multinational Studies	Lachlan McDowell, Sujith Baliga, Luiz Kowalski, Sue Yom, Christina Henson

Please join us at the pre-meeting expo from 4:00 PM – 6:00 PM in room 522ABC for a hands-on learning experience supported in part by Cook Medical.

8:00 AM – 9:30 AM
Opening Ceremony

9:30 AM – 10:15 AM
John J. Conley Lecture
Introduction: Brian Burkey

10:15 AM – 10:45 AM
Break in Exhibit Hall
Room 220BCDE

10:45 AM – 12:15 PM
Controversies in Osseus Reconstruction
Moderator: Jonathan Clark

In this session we will discuss a variety of controversial topics in osseous free flap reconstruction of the maxilla and mandible. This will range from the management of hardware-related and other complications, the use of scapular, iliac crest and other non-fibula flaps, when virtual surgical planning is required, and how patient reported outcome measures can be integrated into routine clinical practice and research. The session will finish with case-based discussion.

At the conclusion of this session, participants will be able to:

• Decide when bone flaps other than the fibula should be considered and understand when virtual surgical planning is a necessity or just a convenience.
• Prevent and better manage complications following osseous free flap reconstruction.
• Integrate patient reported outcomes into routine clinical care following jaw reconstruction.

10:45 AM	Virtual Surgical Planning – Necessity or Convenience	Neal Futran
11:00 AM	Management of Plate Infections, Plate Failure, Postoperative Fistula and Other Complications Following Jaw Reconstruction	Liana Puscas
11:15 AM	Non-fibula Flaps in Jaw Reconstruction	Kyle Mannion
11:30 AM	Integrating Objective and Patient Reported Outcomes into Jaw Reconstruction	Julia Maclean
11:45 AM	Case Presentations and Discussion

10:45 AM – 12:15 PM
New Concepts in Head and Neck Cancer Epidemiology
Moderator: Carole Fakhry

This session will review the epidemiology of human papillomavirus in head and neck cancer. Discussion of the potential role of liquid biopsy will be discussed in both the prevention and surveillance settings.

At the conclusion of this session, participants will be able to:

• Identify the role of HPV in non-oropharyngeal cancer.
• Articulate the state of primary and secondary prevention for HPV-related oropharynx cancer.
• Discuss the potential benefits and limitations of knowledge regarding liquid biopsy in surveillance for HPV-related oropharynx cancer.

10:45 AM	Epidemiologic Nuances in HPV and Head and Neck Cancer (Oropharynx and Non-oropharynx)	Eleni Rettig
11:05 AM	Primary and Secondary Prevention	Gypsyamber D’Souza
11:25 AM	Liquid Biopsy in the Surveillance Setting for HPV-related Head and Neck Cancers Setting	David Neskey
11:45 AM	Panel Case Discussion

10:45 AM – 12:15 PM
Transoral Minimally Invasive Surgery: Controversies and Cases
Moderator: Chris Holsinger

Transoral Minimally Invasive Surgery using traditional approaches, the robot or laser plays an important role in managing oral and oropharyngeal cancers. From the role of TLM to management of retropharyngeal adenopathy and free-flap reconstruction, this panel will address time-honored and cutting-edge technique and research including a discussion of international ongoing clinical trials research.

At the conclusion of this session, participants will be able to:

• Articulate the role of technology (traditional electrocautery, robotics and/or laser) in transoral minimally invasive head and neck surgery.
• Describe ongoing prospective clinical trials in transoral minimally invasive head and neck surgery.
• Define the role of free-flap reconstruction after transoral robotic surgery for oropharyngeal cancers.

10:45 AM	Prospective Clinical Trials in Transoral H&N Surgery: From Best-of to Pathos	Christian Simon
11:00 AM	To Flap or Not to Flap: The Role of Salvage TORS After Previous XRT	Elizabeth Nicolli
11:15 AM	Don’t Forget the Laser? The Role of TLM in 2023	Bruce Haughey
11:30 AM	Transoral Robotic Approach for Retropharyngeal Lymph Node (RPLN) Metastasis: Controversies and Technique	Eun Chang Choi
11:45 AM	It’s a Trap! Refining Traditional Transoral Approaches for Oral Cavity Cancer	Ashok Shenoy
12:00 PM	Q&A

10:45 AM – 12:15 PM
Proffered Papers Sessions
1 – Cancer Biology (1)
2 – Endocrine (1)
3 – Radiation (1)
4 – Reconstruction (1)
5 – Oropharnyx (1)

Industry Symposia (Concurrent Sessions)
12:15 PM – 1:45 PM
Lunch provided

Room 518ABC
Presented by Regeneron
Speaker: Badri G. Modi, MD
Title: Co-managing Patients with Advanced Basal Cell Carcinoma (aBCC) and Advanced Cutaneous Squamous Cell Carcinoma (aCSCC) in the Immunotherapy Era

Room 519AB
Presented by Naveris 
Presenters: Chris Holsinger, MD, FACS; Glenn Hanna, MD; Bhisham Chera, MD
Topic: From Insight to Action: A Case-based Discussion on the Utility of NavDx^®: A Unique Blood-Based DNA Test for HPV-Driven Oropharyngeal Cancer

1:45 PM – 3:15 PM
Laryngeal Preservation
Moderator: Cherie-Ann Nathan

In 2017, an ASCO Expert Panel reviewed evidence that supports treatment strategies intended to preserve laryngeal function and published comprehensive guidelines. Hence we will review and address the 2017 guidelines and literature that supports those guidelines and additional data that has emerged over the past 5 years including immunotherapy trials. We will have talks addressing multimodality treatment and rehabilitation for the first half of the session followed by case presentations.

At the conclusion of this session, participants will be able to:

• Determine what are the larynx-preservation treatment options for advanced-stage (T3, T4) and neck nodes that do not compromise survival, and what are the considerations in selecting among them.
• Identify role of neoadjuvant chemotherapy and immunotherapy in larynx cancer.
• Determine the best measures to evaluate airway, voice, and swallowing function to determine the best function-preservation treatment or to recommend laryngectomy and for the pre- and post-treatment assessment of function.

1:45 PM	Introduction	Cherie-Ann Nathan
1:47 PM	When are Radiation-Based Approaches for Larynx Preservation Appropriate? Weighing Cancer Control and Function with Modern Techniques	Beth Beadle
1:57 PM	Neoadjuvant Approaches to Larynx Preservation	Robert Haddad
2:07 PM	Is There a Role for Conservation Laryngeal Surgery in 2023?	Michael Hinni
2:17 PM	Open Partial Horizontal Laryngectomy Type II for the Management of T1b-2 Glottic SCC	Fernando Dias
2:27 PM	Speech and Swallow Rehabilitation after Laryngeal Cancer	Karuna Dewan
2:37 PM	Case Discussions

1:45 PM – 3:15 PM
Scary Cases – Managing Head and Neck Complications
Moderator: Mark Wax

We will use a case management format to discuss unusual and difficult to manage circumstances following head and neck ablative and reconstructive surgery. Each presenter will present a case that was difficult to manage and perhaps had a suboptimal outcome. Panelists will then be asked for suggestions as to how to optimize management.

At the conclusion of this session, participants will be able to:

• Demonstrate understanding of how suboptimal outcomes can develop.
• Understand the role of examining the outcome to formulate a learning paradigm for the future.
• Integrate multiple approaches to solving difficult situations.

1:45 PM	Reconstructive Scalp Complications	Mark Wax
1:57 PM	Reconstructive Laryngopharyngectomy Complications	Nicole Fowler
2:09 PM	Intractable Bleeding (Thyroidectomy/Neck Dissection)	Raymond Chai
2:21 PM	Reconstruction in the Elderly	Neerav Goyal
2:33 PM	Reconstructive Mandible Complications	Tamer Ghanem
2:45 PM	Long-term Impact of Radiotherapy	Richard Hayden
2:57 PM	The Hostile Neck!	Audrey Baker
3:09 PM	Q&A

1:45 PM – 3:15 PM
Tumor Board Topics: Skin Cancer
Moderator: Kevin Emerick

This session will use a cased based tumor board format to highlight the key principles in the management of advanced skin cancers. We will focus on the growing role of systemic therapies and evolving roles for surgery and radiation.

At the conclusion of this session, participants will be able to:

• Describe the current common practice for systemic therapy in the neoadjuvant and adjuvant setting for melanoma.
• Understand the current indications for systemic therapy in locally advanced and metastatic non melanoma skin cancers.
• Be able define the role for surgical management of skin cancers as well the role for radiation in the primary and adjuvant setting.

Panelists: Laura Ferris, Felix Nguyen, Kirsten Stenson, Michael Gibson, Trinicia Cannon

1:45 PM	Introduction	Kevin Emerick
1:50 PM	Prevention and Initial Treatment for Primary Lesions and Regionally Metastatic  Lymph Nodes
2:20 PM	Adjuvant Treatment for Advanced and Regionally Metastatic Skin Cancers
2:50 PM	Neoadjuvant Treatment for Advanced Skin Cancers

1:45 PM – 3:15 PM
Proffered Papers Sessions
6 – Cancer Biology (2)
7 – Oral Cavity (1)
8 – Skin (1) & Hot Topics (1)
9 – Reconstruction (1)
10 – Salivary (1)

3:15 PM – 3:45 PM
Break in Exhibit Hall
Room 220BCDE

3:45 PM – 5:15 PM
Controversies in N0 neck
Moderator: Yelizaveta Shnayder

This session will present information on controversial issues in management of the cervical lymph nodes in N0 neck including oral cavity cancers, HPV positive and negative oropharynx cancers and thyroid cancers. This is a multidisciplinary panel which includes head and neck surgeons, radiation oncologists and craniomaxillofacial surgeons. This panel will be interactive and include question and answer session and case based discussions.

At the conclusion of this session, participants will be able to:

• Recognize controversial issues in management of N0 neck in oral cavity cancers.
• Recommend radiation approaches in treating cervical lymph nodes in head and neck cancers.
• Discuss treating N0 neck in well differentiated thyroid cancer.

3:45 PM	Introduction and Background	Yelizaveta Shnayder
3:50 PM	Management of N0 Neck in Oral Cavity	Steffen Koerdt
4:05 PM	N0 Neck in Oropharynx Cancer: HPV Positive vs Negative	Amit Agrawal
4:20 PM	N0 Neck in Well Diff Thyroid Ca	Claudio Cernea
4:35 PM	Radiation Approaches to Treating N0 Neck in Head and Neck and/or Other Cancers	Eddy Yang
4:50 PM	Cases and Q&A

3:45 PM – 5:15 PM
Impact of COVID-19 on Patient Care and Workforce – Update 2023
Moderator: Jonathan Irish

This session brings together national and international health system leaders and will discuss the impact of Covid-19 on our national and international health care systems. The session will discuss the immediate impact on patient care (surgery, medical, radiation, screening), the longer term impact on patient care (late stage presentation, survival impact) and discuss how the pandemic affected the health care provider. The session will conclude with what lessons were learned and potential solutions for the future.

At the conclusion of this session, participants will be able to:

• Articulate the variations in health system responses during the pandemic and how these responses impacted patient care.
• Integrate some of the lessons learned and processes implemented from the Covid-19 experience into health care delivery for the future.
• Plan for future pandemics and major disruptions in care in health care systems from the lessons learned from the Covid-19 pandemic.

3:45 PM	Introduction	Jonathan Irish
3:50 PM	The Acute Response at ‘Ground Zero’ – Italy/Europe	Stefano Taboni
4:02 PM	The Acute Response at ‘Ground Zero’ – New York	Vikas Mehta
4:14 PM	The Long Term Impact on Patient Care  – Canada	Jonathan Irish
4:26 PM	The Long Term Impact on Patient Care – USA	Deepa Danan
4:38 PM	The Long Term Impact on Health Systems and Lessons Learned	Michael Kupferman
4:50 PM	The Long Term Impact on Health Systems and Lessons Learned	Bevan Yueh
5:05 PM	Q&A

3:45 PM – 5:15 PM
Tumor Board Topics: Indications for Adjuvant Therapy
Moderator: Eric Genden

We will use a series of challenging cases and audience participation to discuss the indications for adjuvant therapy and implications of adjuvant therapy on outcomes and quality of life.

At the conclusion of this session, participants will be able to:

• Articulate the indications and contraindications for implementing adjuvant therapy.
• Identify patients that would benefit from standard adjuvant therapy or would be beTter served in a clinical trial.
• Predict the impact of adjuvant therapy on treatment outcomes and quality of life.

3:45 PM	What is the State of Adjuvant Therapy for the Management of Head and Neck Malignancy?	Eric Genden
3:55 PM	The Role of Adjuvant Radiotherapy in the Management of Oral/Oropharynx Cancer	James Caudell
4:15 PM	The Role of Adjuvant Therapy Following Salvage Surgery	Ara Chalian
4:35 PM	The Role of Adjuvant Systemic Therapy and Immunotherapy in the Management of Oral/Oropharynx Cancer	Nabil Saba
4:55 PM	Case Presentations and Discussion

3:45 PM – 5:15 PM
Video Session I
Moderators: Gina Jefferson and Sandeep Samant

We will use a case presentation format with videos to discuss the management of cancer of the oropharynx and parapharyngeal space tumors. The discussion will include management of the unknown primary, tonsil and base of tongue cancer resections, prevention of complications, approach to parapharyngeal space tumors, and robot-assisted neck dissection.

At the conclusion of this session, participants will be able to:

• Employ surgical strategies for management of the unknown primary tumors.
• Distinguish the nuances of different robotic platforms for approach to oropharynx tumors.
• Assess the benefits and drawbacks of robot-assisted neck dissection.

3:45 PM	Approach to Unknown Primary	Enver Ozer
4:05 PM	Robotic Management of Tonsil Cancer	Jeffrey Houlton
4:20 PM	Xi set up for TORS, Parapharyngeal Space Tumor Resection	Andrew Holcomb
4:35 PM	Prevention and Management of Vascular Injury	Steve Kim
4:40 PM	Robot-Assisted Neck Dissection	Sandeep Samant
5:10 PM	Q&A

3:45 PM – 5:15 PM
Proferred Papers Sessions
11 – Nasopharynx (2)
12 – Oropharynx (1)
13 – Immunotherapy (1)
14 – Functional (1)
15 – Salivary (1)

3:45 PM – 5:15 PM
Equity, Inclusion, and the Challenges Facing Underrepresented Surgeons: From Fairness to Effectiveness
Supported by a generous educational grant from Intuitive Surgical
Moderator: Trinita Cannon

We will use a moderated panel discussion to address issues regarding equity & inclusivity in pay, opportunities for leadership and career advancement as it pertains to the Head and Neck Surgeon work force.

At the conclusion of this session, participants will be able to:

• Recognize that despite some advances in diversity, equity, and inclusion, we are seeing uneven results in terms of representation for non-majority individuals in medicine.
• Highlight and discuss measures for gender neutral hiring and promotion practices within academic medicine.
• Define best practices for implementing Gender Salary Equity and Increase awareness of the current gaps in LGBTQIA academic medicine.

3:45 PM	Equity, Inclusion, and the Challenges Facing Underrepresented Surgeons: From Fairness to Effectiveness	Trinita Cannon
3:50 PM	Principles & Approaches for Inclusion of LGBTQIA in Academia and AHNS	Ellie Maghami
4:07 PM	Principles for Guiding Gender Equity in Faculty Hiring and Promotion Supporting Diversity and Inclusion	Greg Kempl
4:24 PM	Effective Methods Used to Ensure Gender Salary Equity	Anna Pou
4:41 PM	Framework for Advancing Equity in Academic Medicine and Science	Francisco Civantos
4:58 PM	Q&A

5:15 PM – 6:45 PM
Welcome Reception (Exhibit Hall Opening)
The AHNS gratefully acknowledges Merck Healthcare KGaA for support of the Welcome Reception.

5:15 pm – 6:45 pm
Additional Support Acknowledgement

6:30 PM – 8:00 PM
Room 516C
Session: Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer – NON-CME
Presenters: Stephen Lai, MD; John De Almeida, MD; Clare Schilling, MD; Steven Chang, MD
Supported by an educational grant from  Cardinal Health Nuclear & Precision Health Solutions
Appetizers, beer, wine and beverages provided

7:30 AM – 9:00 AM
Milton J. Dance Symposium: Improving Outcomes Through Collaboration and Discovery for HNSCC
Moderator: Bevan Yueh

This Symposium will highlight the newest approaches and technologies with potential to improve functional outcomes and quality of life after treatment for H&N cancer. We will focus our discussion on how to consider trade-offs between costs of new technologies, potential sacrifices in survival, and better functional and patient-reported outcomes.

At the conclusion of this session, participants will be able to:

• Describe newest developments in peri-operative and intra-operative molecular imaging.
• Convey the impact of recent and future RCTs on functional outcomes and quality of life.
• Appreciate the dilemma of simultaneously achieving lower costs, better survival, and improved functional outcomes.

7:30 AM	Introduction	Bevan Yueh
7:40 AM	Short and Long Term Reduction of Toxicities in Targeted Therapies	Eben Rosenthal
7:55 AM	Clinical Trial Approaches in Radiotherapy to Reduce Toxicity and Improve QOL	Quynh-Thu Le
8:10 AM	Treatment Optimization for Early Stage HPV-Associated Oropharynx Cancer	Barbara Burtness
8:25 AM	Next-generation Clinical Trials of Transoral H&N Surgery: From PATHOS to Precision PORT	Chris Holsinger
8:40 AM	Q&A

9:00 AM – 10:00 AM
Hayes Martin Lecture Introduction
Introduction: Brian Burkey
Keynote: Theodoros Teknos

10:00 AM – 10:30 AM
Break in Exhibit Hall
Room 220BCDE

10:30 AM – 12:00 PM
Immunotherapy as Combined Modality Therapy (non CME)
Moderator: Joseph Curry

This session will review therapeutic strategies to enhance the efficacy of anti-PD1 immune checkpoint inhibition. The panel will review combining anti-PD1 therapy with surgery, radiation and other immune and tumor modulating therapies.

At the conclusion of this session, participants will be able to:

• Articulate current strategies for enhancing aPD1 immune therapy response.
• Evaluate current data on therapeutic emerging strategies for immunotherapy.
• Relate the potential benefits for patients receiving immunotherapy in combination with other approaches.

10:30 AM	Combining Radiation with Immunotherapy to Enhance Efficacy	Aaron Popovtzer
10:45 AM	Anti-PD1 Therapy In Combination with Surgery: Neoadjuvant Approaches to Surgery	Dan Zandberg
11:00 AM	Novel Immunotherapy Combinations to Enhance Anti-PD1 Therapy Responses	Andrew Sikora
11:15 AM	Cutting Edge Technologies and Approaches to Optimize Anti-PD1 Therapy in HNSCC	Young Kim
11:30 AM	Anti-PD1 Therapies in the Management of CSCC and BCC in the Head and Neck	Matt Fury
11:45 AM	Q&A

10:30 AM – 12:00 PM
Improving Quality in Head and Neck Cancer
Moderator: Bert O’Malley

We will use a presentation and discussion format to introduce the concept of a ‘Quality Agenda’ and how collaboration among our specialty societies can drive quality and outcome improvement in our field of head and neck oncology. With detailed examples, we will discuss quality measurement strategies, outline key components of infrastructure that are needed to achieve quality, and introduce ways to improve outcomes ranging from palliative care initiatives to quality assurance programs for head and neck cancer clinical trials.

At the conclusion of this session, participants will be able to:

• Demonstrate an understanding of the concept of a Quality Agenda.
• Identify key infrastructure required to support quality improvement efforts.
• Evaluate the benefits of palliative care initiates and clinical trials quality assurance programs in driving outcomes improvement for head and neck cancer patients.

10:30 AM	Introduction	Bert O’Malley
10:35 AM	Safety vs Quality?	Bert O’Malley
10:40 AM	Establishing a Quality Agenda for Head and Neck Cancer Patients	Brian Nussenbaum
10:55 AM	How the AHNS Can Lead Quality Improvement:  Lessons from the Value and Quality Care Committee	Vasu Divi
11:10 AM	Embedded Palliative Care in the Head and Neck Cancer Clinic	Miriam O’Leary
11:25 AM	Surgical Quality Assurance in Head and Neck Cancer Trials	Christian Simon
11:40 AM	Q&A

10:30 AM – 12:00 PM
Oral Cavity Panel: Advanced Stage
Moderator: Peter Dziegielewski

A multi-disciplinary case management approach will be used to discuss challenging advanced oral cavity cancers. Decision making, treatment options, outcomes and controversies will be presented.

At the conclusion of this session, participants will be able to:

• Integrate a multis-disciplinary counsel to improve patient centered treatment planning.
• Convey expected outcomes of advanced oral cancer treatment.
• Develop survivorship plans for patients with significant functional deficits after advanced oral cavity cancer treatment.

10:30 AM	Extent of Resection / Margins	Steven Cannady
10:45 AM	Adjuvant Radiation	Sharon Spencer
11:00 AM	Liquid Biopsy / Recurrence Prevention	Uttam Sinha
11:15 AM	Speech and Swallowing Rehabilitation	Rosemary Martino
11:30 AM	Reconstructive Challenges	Peter Dziegielewski
11:45 AM	Q&A

10:30 AM – 12:00 PM
Salvage Surgery in 2023
Moderator: Sarah Rohde

We will review the patient prognosticators in salvage surgery followed by a case based review and discussion of site specific considerations. The ethical considerations in salvage surgery will be identified and explored.

At the conclusion of this session, participants will be able to:

• Convey patient prognosticators in salvage surgery and recognize the importance of multi-disciplinary decision making.
• Distinguish the site specific considerations in salvage surgery.
• Recognize ethical considerations surrounding salvage surgery.

10:30 AM	Introduction and Patient Prognosticators in Salvage Surgery	Sarah Rohde
10:48 AM	Oropharyngeal Salvage Surgery	Jeremy Richmon
11:06 AM	Laryngeal & Hypopharyngeal Salvage Surgery	Richard Smith
11:24 AM	Oral Cavity Salvage Surgery	Marita Teng
11:42 AM	Ethical Considerations in Salvage Surgery	Andrew Shuman

10:30 AM – 12:00 PM
Proferred Papers Sessions
27 – Hypopharnyx (2)
28 – Imaging (3)
29 – Endocrine (3)
30 – Reconstruction (3)

12:30 pm – 2:00 pm  
Industry Symposium
Lunch provided
Room 516C
Presented by Exelexis            
Presenters: Siddharth Sheth, DO, MPH 
Title: An Exelixis Product for the Clinical Management of Appropriate Patients in Differentiated Thyroid Cancer 

1:30 PM – 3:00 PM
Complexities in Staging Head and Neck Cancer
Moderator: William Lydiatt

We will use presentations to outline the key issues of staging head and neck cancer as the 9th Edition of the AJCC and UICC manuals are being developed. Case presentations will illustrate some of these complexities.

At the conclusion of this session, participants will be able to:

• Compare and contrast the key issues necessary to create an equitable and predictive staging system.
• Identify the radiographic and physical examination complexities of staging HNC.
• Understand the importance of nodal, biologic, non-anatomic and other data that may be utilized in staging.

1:30 PM	Overview of Staging Changes for the Eighth Edition	William Lydiatt
1:44 PM	Role of Radiology in Staging Specific Questions	Barton  Branstetter
1:58 PM	Importance of Physical Examination in Staging	Trevor Hackman
2:12 PM	The Role of Non-anatomic Factors in Staging	Barbara Wollenberg
2:26 PM	The Cyclical Influence of Staging on Treatment Paradigms	Snehal Patel
2:38 PM	Bringing it all Home: Cases That Illustrate Concepts	Dimitrios Colevas

1:30 PM – 3:00 PM
Controversies in Early-Stage Thyroid Cancer
Moderator: Louise Davies

Does a small tall cell cancer need a total thyroidectomy, and what about contralateral nodules in papillary microcancers? Come hear experts present and discuss their commonly encountered but difficult scenarios: learn updated evidence, pearls for approaching the thought process and tips for communicating the issues clearly and efficiently to patients.

At the conclusion of this session, participants will be able to:

• Convey current evidence around options for patients with commonly encountered but difficult early-stage thyroid cancer scenarios.
• Distinguish which controversies are related to issues around patient preferences and those that are related to issues around medical evidence, to assist in discussions with patients.
• Articulate communication pearls that can help foster satisfying and efficient discussions with patients as they consider their options.

1:30 PM	Introduction	Louise Davies
1:35 PM	Is Lobectomy Enough for Early Stage Tall Cell Cancer?	Ian Ganly
1:50 PM	Choosing Extent of Surgery When There are Contralateral Nodules	Joseph Scharpf
2:05 PM	What is the Downside of Lobectomy for all Papillary Cancers that Don’t Have Metastases?	Babak Givi
2:20 PM	How Important is Macroscopic Nodal Disease in Young People?	Paul O’Neill
2:35 PM	Active Surveillance or Surgery for Early Papillary Cancers	Roberto Lima
2:50 PM	Q&A

1:30 PM – 3:00 PM
Laryngeal Cancer – Late-Stage Controversies
Moderator: D. Gregory Farwell

World experts in multidisciplinary head and neck oncologic care will discuss contemporary management of advanced laryngeal cancer. We will use case-based scenarios to demonstrate optimal personalized approaches to these tumors.

At the conclusion of this session, participants will be able to:

• Apply current evidence for optimal oncologic treatment for advanced stage laryngeal cancer.
• Predict which patients are good functional candidates for non-surgical primary treatment for advanced stage laryngeal cancer.
• Recognize disease-specific and patient-specific variables that will inform personalized treatment approaches.

1:30 PM	Session Introduction	D. Gregory Farwell
1:32 PM	Key Surgical Pearls	Jeffrey Liu
1:37 PM	Key Radiation Oncology Pearls	Houda Bahig
1:42 PM	Key Medical Oncology Pearls	Dan Zandberg
1:47 PM	Key Perioperative Pearls	Kenneth Byrd
1:52 PM	Key Functional Predictor Pearls	Liza Blumenfeld
1:57 PM	Case Based Discussion

1:30 PM – 3:00 PM
Video Session III: State of the Art Surgical Techniques and Innovation
Moderator: Matthew Old

We will use a case-based hybrid video format to highlight innovative approaches and state of the art surgical techniques to common and uncommon head and neck pathology.  

At the conclusion of this session, participants will be able to:

• Recognize the different techniques to approach common and uncommon head and neck pathology.
• Recognize the importance of innovation in head and neck surgery.
• Formulate unique treatment plans for uncommon tumors.

1:30 PM	Introduction	Matthew  Old
1:35 PM	Approaches to the Parapharyngeal Space and Resection of Paragangliomas	James Netterville
1:50 PM	Resection and Management of Vagal Neurofibroma	Anna Pou
2:05 PM	Flap Reconstruction and Rehabilitation for Transoral Robotic-Assisted Surgery	Fred Baik
2:20 PM	Robotic Parathyroidectomy Through the Trans-Hairline Approach	Tsung-Lin Yang
2:35 PM	Transoral Video Laryngoscopic Surgery for Laryngopharyngeal Cancer	Koji Araki
2:50 PM	Q&A

1:30 PM – 3:00 PM
Proferred Papers Sessions
31 – Cancer Biology (4)
32 – Oropharynx (4)
33 – Salivary (2)
34 – Immunotherapy (3)

3:30 PM – 5:00 PM
Controversial Topics in Thyroid Management
Moderator: Jeffrey Bumpous

We will discuss an evidence-based, practice guideline optimized approach to the surgical management of well-differentiated thyroid cancer, as well as best practices in the diagnosis and management of the compressive thyroid goiter. We will also appraise the role of advanced intraoperative technologies in the contemporary performance of thyroid and parathyroid surgery.

At the conclusion of this session, participants will be able to:

• Determine the extent of treatment necessary for well-differentiated thyroid cancer based on clinical and biomarker risk assessment.
• Determine the best approach for management of substernal thyroid goiters.
• Discuss the rationale and cost-effective use of advanced surgical technologies in thyroid surgery.

3:30 PM	Evidence-Based, Practice Guideline Optimized Approach to the Surgical Management of Well-Differentiated Thyroid Cancer	Ellie Maghami
3:50 PM	Best Practices in the Diagnosis and Management of the Compressive Thyroid Goiter	David Shonka
4:10 PM	The Role of Advanced Intraoperative Technologies in the Contemporary Performance of Thyroid and Parathyroid Surgery	Erivelto Volpi
4:30 PM	Thyroid Surgical Cases
4:50 PM	Q&A

3:30 PM – 4:45 PM
Highlights from the Korean Head and Neck Society Symposium: The Cutting Edges – Minimally Invasive and Hidden Scar Surgery in Head and Neck
Moderators: Kwang Hyun Kim and Kwang Jae Cho

We will present the cases and their associated video-clips to show and discuss about remote access or trans-oral surgery for head and neck cancer using endoscopy or robot to minimize surgical morbidity and postoperative scar.

At the conclusion of this session, participants will be able to:

• Understand minimally invasive and hidden scar surgery is a dedicated procedure to extirpate the tumor completely with high magnification, as well as to minimize surgical morbidity and postoperative scar.
• Discuss the advantages and disadvantages of minimally invasive and hidden scar surgery in comparison with conventional procedures.
• Prepare and conduct minimally invasive and hidden scar surgery.

3:30 PM	Remote Access “Scarless” Thyroidectomy	Jun Ook Park
3:45 PM	Robotic and Endoscopic Surgery for Salivary Gland Tumor	Chul Ho Kim
4:00 PM	Robotic Surgery for Para-pharyngeal Space Tumor and Retro-pharyngeal Lymph Node	Yoon Woo Koh
4:15 PM	Latissimus Dorsi and Scapular Tip Flap Harvest with Axillary Approach	Soon Hyun Ahn
4:30 PM	Trans-oral Video-laryngoscopic Surgery for Laryngo-hypopharyngeal Cancer	Il Seok Park

3:30 PM – 5:00 PM
Surgical Innovation in Imaging  
Moderator: Maie St John

We will use a panel presentation format to discuss state of the art innovations in surgical imaging and discuss collaborative pathways forward for multiple techniques in surgical imaging.

At the conclusion of this session, participants will be able to:

• Articulate state of the art innovations in surgical imaging.
• Identify collaborative pathways forward for multiple techniques in surgical imaging.
• Recognize surgical imaging techniques that can be used in their own cases for optimal patient outcomes.

3:30 PM	Precision Surgery: New Frontiers in Head and Neck Cancer	Maie St. John
3:43 PM	AI-supported NBI – Current State and Future Perspectives	Christian Betz
3:56 PM	Image Guided Oral Diagnosis Using Confocal Laser Endomicroscopy	Camile Farah
4:09 PM	Image Guided Surgery Using Fluorescent Tracers	Max Witjes
4:22 PM	Intraoperative Nerve-Specific Fluorescence Imaging	Ryan Orosco
4:35 PM	Nanoparticle Theranostics for Head and Neck Cancer Patients	Nidal Muhanna
4:48 PM	Q&A

3:30 PM – 5:00 PM
What Data is There to Support De-escalation?
Moderator: Quynh-Thu Le

We will be using a panel format to discuss the different approaches to treatment de-escalation in good risk HPV-related oropharyngeal cancers. Risks and benefits of each approach based on available data will be presented.

At the conclusion of this session, participants will be able to:

• Identify the appropriate patient group for treatment de-escalation.
• Differentiate the different approaches to treatment de-escalation.
• Articulate the pros and cons to each approach.

3:30 PM	The Role of Surgery and Lessons Learned from De-escalation Studies so Far	Hisham Mehanna
3:50 PM	Radiation De-escalation – Given the Current Evidence, What Should We Be Doing Right Now?	June Corry
4:10 PM	The Role of Systemic Therapy in Treatment De-escalation	Saad Khan
4:30 PM	Case Presentation and Discussion
4:50 PM	Q&A

3:30 PM – 5:00 PM
Proferred Papers Sessions
35 – Radiation (3)
36 – Oral Cavity (4)
37 – Functional (3)
38 – Education (2)

5:15 PM – 6:15 PM
Robotic Shark Tank (non-CME)
Chair: Jeremy  Richmon, MD

This non-CME presentation will bring together four promising emergent robotic companies and a panel of innovators, investors and skeptics in an informal and fun Shark Tank format immediately before the Presidential Reception. There will be light appetizers and drinks available at the conclusion of the session to allow for networking and interface with audience members.  At the conclusion of the hour, the panel of judges will select the “winners.”

JUDGES
Chris Holsinger, MD, Professor of Head and Neck Surgery, Stanford University
Dion Madsen, B.Comm, CFA, Amplitude Ventures
James Netterville, MD, Professor of Otolaryngology and Director of the Division of Head and Neck Surgery, Vanderbilt University
Kathryn M. Van Able, MD, Mayo Clinic, Rochester

ROBOTIC COMPETITORS
CMR
Galen Robotics
Medical Microinstruments

7:00 PM – 10:00 PM
Presidents’ Reception at the Windsor Ballrooms

7:30 AM – 8:15 AM
Awards Ceremony

8:15 AM – 8:30 AM
Closing Comments

8:30 AM – 9:15 AM
Christopher O’Brien Lecture
Introduction: Eben Rosenthal
Keynote: Hisham Mehanna

9:30 AM – 11:00 AM
The Origin of AHNS: 25th Anniversary Forum 
Moderator: Melonie Nance

We will present a narrative history of the merger of the SHNS and ASHNS in 1998 and how this resulted in the current AHNS. This will include first hand narrative of these events from senior leaders who were involved at that time, including the past Presidents of the SHNS and ASHNS at the time of the merger.

At the conclusion of this session, participants will be able to:

• Understand how the American Head and Neck Society was formed.
• Understand the perspective of each of two different Surgical specialties who perform Head & Neck Surgery.
• Recognize the contributions of senior leaders in establishing the AHNS 25 years ago.

9:30 AM	Background of Two Head & Neck Societies	Melonie Nance
9:45 AM	SHNS Perspective with Q&A	Ashok Shaha
10:05 AM	ASHNS Perspective with Q&A	KT Robbins
10:25 AM	The Significance of the New Society: AHNS	Eugene Myers
10:45 AM	Past, Present and Future of AHNS	Joseph Goodman

9:30 AM – 11:00 AM
Do We have Consensus on Surgical Margins?
Moderator: Michael Topf

Although head and neck oncologists agree that surgical margin status is a critical prognostic factor, consensus on many surgical margin topics remains challenging. In this panel, speakers will discuss areas of controversy and general agreement on surgical margins, and will also explore future directions and novel approaches to surgical margin analysis.  

At the conclusion of this session, participants will be able to:

• Identify controversies in surgical margins for mucosal squamous cell carcinoma.
• Interpret the literature on margin analysis, frozen sections, and management of a positive margin.
• Evaluate future directions and novel approaches to margin analysis including 3D scanning of surgical specimens and fluorescence-guided sampling.

9:30 AM	Introduction / Overview of Surgical Margins	Michael Topf
9:40 AM	Surgical Margin Considerations in HPV-Positive Oropharyngeal Cancer	Vinidh Paleri
9:50 AM	What Happens in the Pathology Suite?	Joseph Valentino
10:00 AM	Specimen-based vs Tumor-bed Approach to Margin Analysis	Stephen Kang
10:10 AM	Are Frozen Sections Evidence Based?	Pankaj Chaturvedi
10:20 AM	Management of the Positive Margin	Stephen Kang
10:25 AM	Shifting the Intraoperative Communication Paradigm with 3D Scanning	Margaret Brandwein-Weber
10:40 AM	The Sentinel Margin	Naoki Nishio
10:45 AM	REIMS (iKnife)	Vinidh Paleri
10:50 AM	Q&A

9:30 AM – 11:00 AM
European Commitment to Survivorship Through Quality and Innovation
Moderator: Terry Day

In line with the conference theme ‘Welcoming Back the World: Striving for Innovation, Quality, Compassion, and Collegiality’, the session will highlight some innovative examples of EHNS-led projects that aim to improve outcomes for people with head and neck cancer (HNC).

At the conclusion of this session, participants will be able to:

• Demonstrate the positive global outcomes achieved by the Make Sense campaign since 2013 and value of implementing awareness campaigns in the HNC setting.
• Provide a detailed overview of the planning, implementation and outcomes of a country- wide HNC screening program.
• Communicate findings from the ‘Oncokompas’ trial that evaluated the efficacy of a fully automated eHealth application to support cancer survivors in their self-management.

9:30 AM	Introduction and Overview	Terry Day
9:35 AM	The Value of Awareness Campaigns in the HNC Setting: An Evaluation of the Make Sense Campaign	Rene Leemans
9:55 AM	Planning, Implementation and Outcomes from a National HNC Screening Program: A Case Series from Poland	Wojciech Golusinski
10:15 AM	Self-management in HNC Survivors	Irma Verdonck-de Leeuw
10:45 AM	Q&A

9:30 AM – 11:00 AM
Proferred Papers Sessions
39 – Biology (5)
40 – Reconstruction (4)
41 – Nasopharynx (2)
42 – Salivary (3)
43 – Hypopharynx (3)

11:00 AM – 12:30 PM
Cancer Screening (non CME)
Moderator: Heather Edwards

Through individual presentations followed by a Q&A period, we will explore issues in head and neck cancer screening and early detection including effective design and implementation of screening programs in different geographic, cultural and health system contexts, and evidence-based application of novel technologies.

At the conclusion of this session, participants will be able to:

• Understand effective design and implementation of successful screening programs in different geographic, cultural and health system contexts.
• Review established and novel technologies that have been applied to screening and early detection.
• Interpret clinical outcomes data regarding efficacy of technologies for screening and early detection, and consider potential applications to various practice models.

11:30 AM	National Screening Program In Taiwan for Oral Cancer	Chih-yen Chien
11:42 AM	Narrow Band Imaging for the Detection of Early Laryngeal Cancer	Edward Damrose
11:54 AM	Cancer Screening in Oral Premalignant Lesions	Carissa Thomas
12:06 PM	Novel Technologies in Screening and Early Detection	Snehal Patel
12:18 PM	Q&A

11:00 AM – 12:30 PM
New Concepts in Management of NMSC
Moderator: Cecelia Schmalbach

We will utilize a combination of panel and case-based presentations to present recent advancements in the management of cutaneous squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma. Focus will include the high risk immunosuppressed patient population, advances in immunotherapy, and related translational research.

At the conclusion of this session, participants will be able to:

• Define management strategies for high risk immunosuppressed cSCC patients.
• Identify the role of PD-1 inhibitors for NMSC (cSCC; BCC; Merkel Cell Ca).
• Identify challenges in cSCC data collection for research and ways to mitigate these barriers.

11:00 AM	Introduction/Objectives/Epidemiology	Cecelia Schmalbach
11:05 AM	Contemporary Approaches to High Risk cSCC Patients	Cecelia Schmalbach
11:20 AM	Immunotherapy: New Frontiers for of NMSC	Ilana Doweck
11:40 AM	Managing the Burden of Disease and Interrogating the Molecular Landscape of cSCC	Bruce Ashford
12:00 PM	Case Presentations
12:15 PM	Q&A

11:00 AM – 12:30 PM
Video Session IV: Thyroid
Moderator: Mark Zafereo

The panelists will use video demonstration and discussion to illustrate new technologies and advanced techniques in thyroid surgery. Topics covered will include continuous nerve monitoring, infrared autofluorescence, medial to lateral thyroidectomy approach, and tracheal resection.

At the conclusion of this session, participants will be able to:

• Evaluate the technique and principles of neuromonitoring and how to utilize laryngeal adductor reflex neuromonitoring data during thyroid surgery to improve outcomes.
• Illustrate how NIRAF technology can be applied in thyroid surgery, including an understanding of common pitfalls and limitations.
• Understand advanced thyroid surgery techniques including medial to lateral thyroidectomy and tracheal resection.

11:00 AM	Introduction	Mark Zafereo
11:05 AM	Continuous Laryngeal Adductor Reflex Monitoring During Thyroid Surgery	Erin Buczek
11:20 AM	Medial to Lateral Approach to Thyroidectomy	Ameya Asarkar
11:35 AM	Near-infrared Autofluorescence Technology in Thyroid Surgery	Amanda Silver-Karcioglu
11:50 AM	Tracheal Resection for Thyroid Cancer	Mark Zafereo
12:05 PM	Q&A

11:00 AM – 12:30 PM
Proferred Papers Sessions
44 – Skin (2)
45 – Oral Cavity (5)
46 – Reconnstruction (5)
47 – Functional (4)
48 – Education (3)

Room 220 BCDE

Sunday, July 9
5:15 PM – 6:45 PM
Opening Reception

Monday, July 10
10:00 AM – 4:00 PM

Tuesday, July 11
10:00 AM – 4:00 PM

Confirmed list of exhibitors

ACERA SURGICAL
Ascendis Pharma
Atos Medical
Axogen
BioSyent Pharma
C2Dx, Inc.
Cardinal Health Medical Affairs
Cardinal Health Nuclear & Precision Health — LYMPHOSEEK(R)
Checkpoint Surgical
Checkpoint Surgical, Inc.
Cook Medical
CranioRehab
ECO Medical Technology (Nanjing) Co., Ltd.
EMD Serono
Exelixis
FLUOPTICS Part of Getinge
InHealth Technologies
Inomed, Inc.
Integra Lifesciences
Interpace Diagnostics
JAMA Network
KARL STORZ Endoscopy America, Inc.
KLS Martin Group
Medical Microinstruments
Medtronic
Merck & Co., Inc.
Naveris, Inc.
Rakuten Medical
Regeneron
Replimune
Stryker
THANC Foundation
True Angle
Vector Surgical
Veracyte, Inc.

Hands-On Learning
Room 220 BCDE

Sunday, July 9
5:15 PM – 6:45 PM
Opening Reception

Monday, July 10
10:00 AM – 4:00 PM

Tuesday, July 11
10:00 AM – 4:00 PM

CARDINAL HEALTH
Visit Cardinal Health’s Learning Center station to learn more about sentinel lymph node biopsy (SLNB) for head and neck cancers.  Surgical experts and Medical Affairs personnel can answer questions, perform lymphatic mapping demos, share clinical trial information, and help identify what you need to start SLNB at your institution.

MMI – Medical Micro Instruments
Interested in learning about robotic microsurgery? Please visit MMI (Medical Microinstruments) in the Learning Center to gain knowledge of the Symani Surgical System and how it is currently being used in head and neck cancer applications. Our team will be available to discuss the system and provide hands-on demonstrations.

The Symani Surgical System is a CE marked (CE 0051) medical device and is approved in Australia by TGA for clinical use. Symani is not cleared or approved for clinical use in any other country.

Hands-On Learning
Room 522 ABC

Saturday, July 8
4:00 PM – 6:00 PM

Join the following companies for hands-on learning related to the pre-meeting courses while enjoying a wine and cheese reception.

The AHNS gratefully acknowledges Cook Medical for their support of the Expo Reception.

Company                            Related Course

Cook Medical                          Salivary

ECO Med Tech                        TORS/Robotics

Medtronic                               Endocrine

MMI                                        TORS/Robotics

Naveris                                    TORS

Sunday, July 9
12:15 PM – 1:45 PM
Lunch provided

Room 518ABC
Presented by Regeneron
Speaker: Badri G. Modi, MD
Title: Co-managing Patients with Advanced Basal Cell Carcinoma (aBCC) and Advanced Cutaneous Squamous Cell Carcinoma (aCSCC) in the Immunotherapy Era

Sunday, July 9
12:15 PM – 1:45 PM
Lunch provided

Room 519AB
Presented by Naveris 
Presenters: Chris Holsinger, MD, FACS; Glenn Hanna, MD; Bisham Chera, MD
Topic: Detection of HPV-Driven OPSCC: Clinical Evidence of an Innovative Blood Test – Clinical Role of NavDx in Managing OPSCC

Sunday, July 9
6:30 PM – 8:00 PM
Appetizers, beer, wine and beverages provided

Room 516C
Supported by an educational grant from  Cardinal Health Nuclear & Precision Health Solutions
Presenters: Stephen Lai, MD; John De Almeida, MD; Clare Schilling, MD; Steven Chang, MD
Topic: Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer

Monday, July 10
12:30 PM – 2:00 PM

Room 516C
Presented by EMD Serono 
Presenters: Robert Ferris, MD; Robert Haddad, MD; Nancy Lee, MD
Title:  Evolving Treatment Paradigm for Patients With LA SCCHN

Monday, July 10 
12:30 pm – 2:00 pm  
Lunch provided

Room 518ABC
Presented by Answers in CME 
Presenters: Emily Ruiz, MD, MPH; Neil Gross, MD, FACS
Title: A Window of Opportunity to Enhance Earlier Use of Immunotherapies in Nonmelanoma Skin Cancers: Moving from Advanced to Neoadjuvant Settings

Tuesday, July 11         
12:30 pm – 2:00 pm  
Lunch provided

Room 516C
Presented by Exelexis            
Presenters: TBA
Title: An Exelixis Product for the Clinical Management of Appropriate Patients in Differentiated Thyroid Cancer 

Visibility Sponsors

GOLD
Naveris

SILVER
EMD Serono

BRONZE
Endo Quest Robotics

Educational Grant Supporters

PLATINUM
Intuitive Surgical

SILVER
Merck Sharp and Dohme

BRONZE
Cook Medical